Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More
With less than a month to go, the Drug Discovery Innovators & Investors (DDII) Digital Forum will bring together leaders and experts from across the drug discovery ecosystem on 30 September 2026 to explore the technologies, strategies, therapies and investment trends shaping the future of early-stage drug discovery. Across four… Read More
This webinar, hosted by DDW, explores how deep learning and physics-based methods can be combined to improve antibody affinity maturation and epitope mapping using workflows available in BIOVIA Discovery Studio Simulation on the 3DEXPERIENCE cloud platform. Through case studies involving antibody-antigen and nanobody-receptor complexes, the work demonstrates how virtual mutagenesis,… Read More
Site management organisation Panthera has opened its latest clinical trial clinic at Keele University, strengthening its growing clinical research network across the UK and Europe. Panthera recruits patients and runs clinical trials on behalf of pharmaceutical companies. The opening of the Keele site brings Panthera’s network to 11 sites, including… Read More
New research has shown that people taking oral semaglutide – the active ingredient used in Wegovy – experienced fewer heavy-drinking days, consumed fewer drinks when they did drink and reported weaker everyday cravings than those given a placebo. The eight-week randomised clinical trial involved 50 adults with moderate-to-severe alcohol use… Read More
The European Commission has granted orphan designation to asedebart (Lu AG13909) to brain health biopharmaceutical company Lundbeck’s novel investigational anti-ACTH monoclonal antibody (mAb), for the treatment of Cushing’s syndrome of endogenous origin. Cushing’s syndrome of endogenous origin includes both ACTH-dependent and ACTH-independent forms. ACTH-dependent Cushing’s syndrome is a rare, serious endocrine… Read More
This webinar, hosted by DDW, explores how deep learning and physics-based methods can be combined to improve antibody affinity maturation and epitope mapping using workflows available in BIOVIA Discovery Studio Simulation on the 3DEXPERIENCE cloud platform. Through case studies involving antibody-antigen and nanobody-receptor complexes, the work demonstrates how virtual mutagenesis,… Read More
Scientists have redefined how the key blood‑clotting protein fibrinogen behaves when it contacts air, overturning two decades of scientific consensus on wound healing. The study, ‘Redefining Fibrinogen Self Assembly at the Air–Water Interface: An Intriguing Story with Multiple Layers’, is the culmination of over a decade of international collaboration by… Read More
This webinar, hosted by DDW, explores how deep learning and physics-based methods can be combined to improve antibody affinity maturation and epitope mapping using workflows available in BIOVIA Discovery Studio Simulation on the 3DEXPERIENCE cloud platform. Through case studies involving antibody-antigen and nanobody-receptor complexes, the work demonstrates how virtual mutagenesis,… Read More
News round-up for 17-21 August by Megan Thomas, Content Team at DDW. This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories: DDII Digital Forum:… Read More
Akiram Therapeutics has signed an agreement with ITM for the supply of non-carrier-added lutetium-177 (n.c.a. Lu-177) to support the ongoing clinical trial of AKIR001, its lead radiopharmaceutical candidate for the treatment of solid tumours. Lu-177 is one of the most widely used medical radioisotopes in targeted radionuclide therapy and serves… Read More
Cumulus Neuroscience, a global digital health company, has published final results from its first-in-class CNS-102 study in Scientific Reports. The study was conducted in collaboration with the PRECISIONALS initiative, a Research Ireland academic–industry collaboration hosted by Trinity College Dublin. The paper, titled “Longitudinal cognitive assessment using the Cumulus NeuLogiq Platform in… Read More
The Drug Discovery Innovators & Investors (DDII) Digital Forum, taking place on 30 September 2026, will bring together experts from across the drug discovery ecosystem to examine the scientific, operational and commercial developments shaping the future of early-stage drug discovery. Following the announcement of the preliminary speaker lineup, we… Read More
BIOCAPTIVA, a University of Edinburgh spin-out that develops advanced technologies to extract cell-free DNA (cfDNA) from blood for cancer liquid biopsies, has appointed experienced life sciences executive, Stephane Argivier as Chair to steer its next phase of international growth. The company’s patented msX platform has the potential to improve the… Read More
The Cambridge Crystallographic Data Centre (CCDC) has launched the CCDC Innovation Fund, a new seed funding programme designed to support emerging companies developing innovative solutions in structural chemistry. The fund, backed by an initial commitment from the CCDC of up to £300,000, will provide early-stage support to start-ups and university spin-outs seeking to transform structural… Read More
Insilico Medicine has introduced biological age as a core condition in virtual cell research with the launch of its Virtual Aging Cell (VAC) Webpage and a preview of its Multi-Agent driven VAC platform. The clinical-stage drug discovery company said the platform represents the industry’s first multi-agent Virtual Aging Cell platform… Read More
